Pzena Investment Management, Inc. (PZN) Receives Average Rating of “Hold” from Brokerages

Shares of Pzena Investment Management, Inc. (NYSE:PZN) have received an average broker rating score of 3.00 (Hold) from the one brokers that cover the stock, Zacks Investment Research reports. One research analyst has rated the stock with a hold rating.

Brokerages have set a 12-month consensus price target of $9.00 for the company and are predicting that the company will post $0.15 EPS for the current quarter, according to Zacks. Zacks has also assigned Pzena Investment Management an industry rank of 19 out of 255 based on the ratings given to its competitors.

Several brokerages have recently issued reports on PZN. Zacks Investment Research cut Pzena Investment Management from a “buy” rating to a “hold” rating in a report on Wednesday. ValuEngine cut Pzena Investment Management from a “hold” rating to a “sell” rating in a report on Monday, March 11th.

A number of large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC raised its holdings in Pzena Investment Management by 6.4% during the 4th quarter. Geode Capital Management LLC now owns 128,146 shares of the asset manager’s stock valued at $1,108,000 after buying an additional 7,740 shares during the period. Dimensional Fund Advisors LP raised its holdings in Pzena Investment Management by 3.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 478,494 shares of the asset manager’s stock valued at $4,139,000 after buying an additional 14,106 shares during the period. Hancock Whitney Corp purchased a new stake in Pzena Investment Management during the 4th quarter valued at $163,000. Bank of America Corp DE raised its holdings in Pzena Investment Management by 46.7% during the 4th quarter. Bank of America Corp DE now owns 11,214 shares of the asset manager’s stock valued at $97,000 after buying an additional 3,570 shares during the period. Finally, Stone Ridge Asset Management LLC raised its holdings in Pzena Investment Management by 5.8% during the 4th quarter. Stone Ridge Asset Management LLC now owns 57,350 shares of the asset manager’s stock valued at $496,000 after buying an additional 3,136 shares during the period. Institutional investors own 16.94% of the company’s stock.

PZN stock traded down $0.03 during midday trading on Wednesday, hitting $8.34. The company’s stock had a trading volume of 79,100 shares, compared to its average volume of 61,950. The company has a market capitalization of $577.14 million, a price-to-earnings ratio of 10.83 and a beta of 1.15. Pzena Investment Management has a 12 month low of $7.36 and a 12 month high of $10.48.

Pzena Investment Management (NYSE:PZN) last issued its quarterly earnings data on Tuesday, February 5th. The asset manager reported $0.16 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.18 by ($0.02). The firm had revenue of $36.40 million for the quarter, compared to analysts’ expectations of $36.79 million. Pzena Investment Management had a return on equity of 15.14% and a net margin of 8.98%. On average, equities analysts predict that Pzena Investment Management will post 0.68 EPS for the current fiscal year.

Pzena Investment Management Company Profile

Pzena Investment Management, Inc is a publicly owned investment manager. The firm manages equity mutual funds for its clients. It invests in the public equity markets. Pzena Investment Management, Inc was founded in 2007 and is based in New York City with additional offices in Melbourne, Australia and London, United Kingdom.

Recommended Story: Is it better to buy a fund with a higher or lower NAV?

Get a free copy of the Zacks research report on Pzena Investment Management (PZN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Pzena Investment Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pzena Investment Management and related companies with MarketBeat.com's FREE daily email newsletter.